P

Inventor

LI NING

US591 patents
⚠️ This page may combine multiple inventors who share the name “LI NING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

19 patents
US11505593B2Nov 22, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations98
US11459374B2Oct 4, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations97
US11174283B2Nov 16, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations97
US11053280B2Jul 6, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA19 citations97
US11542317B1Jan 3, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA11 citations94
US11485770B2Nov 1, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA6 citations94
US11459373B2Oct 4, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations94
US11306135B2Apr 19, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA7 citations94
US11299532B2Apr 12, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations94
US11186625B2Nov 30, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA10 citations94
US11958894B2Apr 16, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA5 citations93
US11753459B2Sep 12, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA5 citations93
US11548932B2Jan 10, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations93
US11535663B2Dec 27, 2022

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA6 citations93
US10342876B2Jul 9, 2019

Process for reducing subvisible particles in a pharmaceutical formulation

REGENERON PHARMA17 citations92
US11472861B2Oct 18, 2022

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA5 citations91
US11104715B2Aug 31, 2021

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA5 citations91
US12012445B2Jun 18, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA4 citations85
US12054532B2Aug 6, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA2 citations84

IBM

7 patents

BROADCOM CORP

5 patents

CIRRUS LOGIC INC

3 patents

LUOYANG GREAT OFFICE FURNITURE CO LTD

2 patents

CIRRUS LOGIC INT SEMICONDUCTOR LTD

2 patents

UNIV MISSOURI

2 patents

FACEBOOK INC

2 patents

REGENERAN PHARMACEUTICALS INC

1 patent

SEAGATE TECHNOLOGY LLC

1 patent

SCHMAP INC

1 patent

UNIV CALIFORNIA

1 patent

SCHOEN KENT

1 patent

BEYER KEVIN SCOTT

1 patent

3I SYSTEMS CORP

1 patent

OREGON STATE

1 patent

Showing the top 50 of 591 patents by PatentIndex Score.